Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

113
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

Author(s)

  | Issue Writer Certificate 

Pages

  1275-1283

Keywords

Not Registered.

Abstract

Cites

References

  • No record.
  • Cite

    APA: Copy

    . (2017). Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. BLOOD, 129(10), 1275-1283. SID. https://sid.ir/paper/738550/en

    Vancouver: Copy

    . Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. BLOOD[Internet]. 2017;129(10):1275-1283. Available from: https://sid.ir/paper/738550/en

    IEEE: Copy

    , “Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab,” BLOOD, vol. 129, no. 10, pp. 1275–1283, 2017, [Online]. Available: https://sid.ir/paper/738550/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    مرکز اطلاعات علمی SID
    strs
    دانشگاه امام حسین
    بنیاد ملی بازیهای رایانه ای
    کلید پژوه
    ایران سرچ
    ایران سرچ
    File Not Exists.
    Move to top